Pfizer gains former Lilly oncology exec
Pfizer taps Garry Nicholson to head its oncology franchise, the firm announces May 14. Nicholson, who served as Lilly's Executive Director of the U.S. Oncology Business Unit, will be senior VP and general manager of Pfizer's new Oncology Business Unit, which was established March 5 with plans to achieve double-digit growth globally for mature products (1"The Pink Sheet," March 10, 2008, p. 5)
You may also be interested in...
As Pfizer faces a future without several key blockbuster drugs, Lipitor among them, the company is setting out to extend the life of its mature franchises with the formation of a dedicated business unit for established brands
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.